Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice
- PMID: 22223728
- DOI: 10.1161/ATVBAHA.111.242800
Regulatory T-cell response to apolipoprotein B100-derived peptides reduces the development and progression of atherosclerosis in mice
Abstract
Objective: The immunoinflammatory response plays a critical role in the development and progression of atherosclerosis. Recent studies suggested an important role for regulatory T (Treg) cells in the inhibition of disease-related vascular inflammation. We hypothesized that induction of a specific Treg cell response to atherosclerosis-relevant antigens would be an attractive strategy to limit the development and progression of atherosclerosis through the promotion of immune tolerance.
Methods and results: Young or old Apoe-/- mice were subcutaneously infused for 2 weeks with either a control ovalbumin (OVA) peptide or with apolipoprotein B100 (ApoB100)-derived peptides without adjuvant. Atherosclerosis development, progression and immunologic status were assessed at 8 weeks after the end of the infusion. Treatment with ApoB100 peptides led to significant reduction of lesion development in young Apoe-/- mice (P=0.001 versus OVA group) and abrogated atherosclerosis progression in old Apoe-/- mice with already established lesions (0% progression in ApoB100 versus 17% in OVA group, P<0.005). Limitation of plaque progression was associated with reduced vascular inflammation and increased collagen content, indicative of plaque stabilization. Infusion of ApoB100 peptides did not alterantibody production but promoted a specific Treg cell response, which was associated with a reduction of both T helper type 1-related and T helper type 2-related cytokines. Interestingly, depletion of CD4+CD25+ Treg cells abrogated ApoB100 peptides-dependent immune modulation and atheroprotection.
Conclusion: Subcutaneous infusion of adjuvant-free ApoB100-derived peptides to Apoe-/- mice reduces atherosclerosis through the induction of a specific Treg cell response.
Similar articles
-
The intravenous injection of oxidized LDL- or Apolipoprotein B100--Coupled splenocytes promotes Th1 polarization in wildtype and Apolipoprotein E--Deficient mice.Biochem Biophys Res Commun. 2015 Aug 14;464(1):306-11. doi: 10.1016/j.bbrc.2015.06.148. Epub 2015 Jun 24. Biochem Biophys Res Commun. 2015. PMID: 26116775
-
Intranasal immunization with an apolipoprotein B-100 fusion protein induces antigen-specific regulatory T cells and reduces atherosclerosis.Arterioscler Thromb Vasc Biol. 2010 May;30(5):946-52. doi: 10.1161/ATVBAHA.109.202671. Epub 2010 Feb 18. Arterioscler Thromb Vasc Biol. 2010. PMID: 20167655
-
Oral FTY720 administration induces immune tolerance and inhibits early development of atherosclerosis in apolipoprotein E-deficient mice.Int J Immunopathol Pharmacol. 2012 Apr-Jun;25(2):397-406. doi: 10.1177/039463201202500209. Int J Immunopathol Pharmacol. 2012. PMID: 22697071
-
Apolipoprotein B100 autoimmunity and atherosclerosis - disease mechanisms and therapeutic potential.Curr Opin Lipidol. 2012 Oct;23(5):422-8. doi: 10.1097/MOL.0b013e328356ec7c. Curr Opin Lipidol. 2012. PMID: 22814703 Review.
-
Regulatory T cells in atherosclerosis: critical immune regulatory function and therapeutic potential.Cell Mol Life Sci. 2016 Mar;73(5):901-22. doi: 10.1007/s00018-015-2080-2. Epub 2015 Oct 30. Cell Mol Life Sci. 2016. PMID: 26518635 Free PMC article. Review.
Cited by
-
Mucosal tolerance to a combination of ApoB and HSP60 peptides controls plaque progression and stabilizes vulnerable plaque in Apob(tm2Sgy)Ldlr(tm1Her)/J mice.PLoS One. 2013;8(3):e58364. doi: 10.1371/journal.pone.0058364. Epub 2013 Mar 11. PLoS One. 2013. PMID: 23505495 Free PMC article.
-
Targeting T cells to treat atherosclerosis: odyssey from bench to bedside.Eur Heart J Cardiovasc Pharmacother. 2016 Jul;2(3):194-9. doi: 10.1093/ehjcvp/pvw001. Epub 2016 Jan 24. Eur Heart J Cardiovasc Pharmacother. 2016. PMID: 27418972 Free PMC article. Review.
-
The Role of the Coagulation System in Peripheral Arterial Disease: Interactions with the Arterial Wall and Its Vascular Microenvironment and Implications for Rational Therapies.Int J Mol Sci. 2022 Nov 29;23(23):14914. doi: 10.3390/ijms232314914. Int J Mol Sci. 2022. PMID: 36499242 Free PMC article. Review.
-
Clonal restriction and predominance of regulatory T cells in coronary thrombi of patients with acute coronary syndromes.Eur Heart J. 2015 May 1;36(17):1041-8. doi: 10.1093/eurheartj/eht543. Epub 2014 Jan 12. Eur Heart J. 2015. PMID: 24419807 Free PMC article. Clinical Trial.
-
Helminth infections, type-2 immune response, and metabolic syndrome.PLoS Pathog. 2014 Jul 3;10(7):e1004140. doi: 10.1371/journal.ppat.1004140. eCollection 2014 Jul. PLoS Pathog. 2014. PMID: 24992724 Free PMC article. Review. No abstract available.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous